ArticleThe journal of headache and pain2024

First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients.

Zhao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.